Trial intelligence / Profile preview

PF-04191834 in Knee Osteoarthritis

NCT01147458Phase 2Terminated

Sponsor
Pfizer
Start
Jul 2010
Primary completion
Feb 2011
Modality
Small Molecules
Countries
3
01

Overview

A Phase 2 trial of PF-04191834 in osteoarthritis (OA), sponsored by Pfizer. Started Jul 2010; status: terminated.

02

Drugs

PF-04191834
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT01147458.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01147458.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call